Invivyd Inc (IVVD)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
CEO: | David Hering |
Employees: | 100 |
Web site: | invivyd.com |
1601 TRAPELO ROAD, SUITE 178, WALTHAM, MA, 02451
(781) 819-0080
|
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Adagio Therapeutics focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease.
Please log in first to see chart